This inventor holds 50 USPTO granted patents, plus 1 CIPO patent, primarily in Erectile Dysfunction Treatment (CPC class 4244). Top assignees: Vivus, Inc., Alza Corporation, Asivi, LLC. Active years: 1976-2007.
Inventors with similar research interests:
Location History:
- Palo Alto, CA (US) (1976)
- Portola Valley, CA (US) (1981)
- Half Moon Bay, CA (US) (1984 - 1986)
- Kawaihe, HI (US) (1992)
- Kawaihee, HI (US) (2001)
- Kawaihae, HI (US) (1988 - 2007)
Company Filing History:
24 out of 45Â 
13 out of 1,062Â 
2 out of 2Â 
Years Active: 1976-2007
Areas of Expertise:
Title: Virgil A Place: Collaborating for Innovations in Female Sexual Dysfunction Treatment
Introduction:
In the world of medical innovations, Virgil A Place has emerged as a leading figure in the field of female sexual dysfunction treatment. Hailing from Kawaihae, Hawaii (US), Place has made significant strides in developing methods and pharmaceutical compositions for addressing this prevalent issue. With an impressive portfolio of patents and a career filled with notable collaborations, Place's contributions have brought new hope to individuals affected by female sexual dysfunction.
Latest Patents:
Place's recent patents demonstrate his dedication to finding effective treatments for female sexual dysfunction. One such patent involves the administration of vasoactive intestinal polypeptide agonists to the vagina and vulvar region. These pharmaceutical compositions not only aim to treat the condition but also improve vaginal muscle tone, tissue health, enhance lubrication, and minimize excess collagen deposition. Additionally, he developed a method centered around the co-administration of prostaglandins and androgenic agents to address female sexual dysfunction.
Career Highlights:
With an extensive career in the field, Place has proven his commitment to advancing medical treatments. Having secured an impressive 50 patents, he has positioned himself as a knowledgeable and innovative expert in the arena of female sexual dysfunction. Throughout his career, Place has been associated with leading pharmaceutical companies, including Vivus, Inc., and Alza Corporation, which have provided robust platforms for his research and development.
Collaborations:
Collaboration has been an integral part of Place's success, as he has worked with various individuals and organizations to bring his ideas to fruition. Two notable collaborators include Paul C Doherty, Jr, and Mark S Hanamoto. By joining forces, these individuals have combined their expertise in medical research and pharmaceuticals, amplifying the impact of their collective efforts.
Conclusion:
Virgil A Place's contributions in the realm of female sexual dysfunction treatment have significantly advanced the understanding and options available to individuals facing this complex issue. With an extensive portfolio of patents, notable collaborations, and a strong professional background, Place has left an indelible mark on the field of innovative medical solutions. As his work continues to evolve and inspire, it is evident that his contributions hold immense potential for improving the lives of those affected by female sexual dysfunction.